Skip to content
Open access

Pseudoendocrine differentiation in colorectal adenoarcinoma associated with EPCAM-mutated Lynch syndrome.

Sep 2026 · Indian Journal of Pathology and Microbiology · Vol 69, pp. 531-534 · 0 citations
Medicine

TL;DR

A rare case of a 29-year-old female with EPCAM-mutated LS presenting as colonic adenocarcinoma with neuroendocrine-like rosette formation is reported, introducing the concept of a possible pseudoendocrine carcinoma arising in an epithelial malignancy.

Abstract

ABSTRACT Lynch syndrome (LS) is an autosomal dominant cancer predisposition syndrome caused by germline mutations in DNA mismatch repair genes or, less commonly, EPCAM deletions. LS-associated colorectal carcinomas often present at a young age and may show unusual histomorphological patterns, posing diagnostic challenges. We report a rare case of a 29-year-old female with EPCAM-mutated LS presenting as colonic adenocarcinoma with neuroendocrine-like rosette formation. The tumor initially mimicked mixed adenoneuroendocrine carcinoma (MANEC) due to biphasic histology and the presence of multiple rosettes. However, immunohistochemistry demonstrated negativity for synaptophysin and chromogranin, excluding true neuroendocrine differentiation with diffuse Pan CK and focal CDX2, CK20 positivity along with loss of MSH2 and MSH6. Further molecular analyses confirmed EPCAM exon 5-9 deletion. The tumor was ultimately classified as an MMR-deficient adenocarcinoma with pseudoendocrine morphology. This case broadens the histomorphological spectrum of LS-associated colorectal carcinomas and introduces the concept of a possible pseudoendocrine carcinoma arising in an epithelial malignancy. Recognition of this pattern is crucial to prevent misdiagnosis as MANEC, to guide appropriate management, facilitate familial screening, and highlight that not every rosette signifies neuroendocrine differentiation; some may represent LS in disguise.

Read PDF

Similar papers

Review Open access Oct 2026

Adenosquamous carcinoma of the colon with an aberrant MLH1 immunostaining pattern: a diagnostic pitfall in mismatch repair assessment

This case illustrates the clinicopathological features of ASC, alongside a dMMR immunoprofile that may carry therapeutic relevance given the efficacy of immune checkpoint inhibitors in MSI-high colorectal tumors, and underscores the importance of correctly recognizing the VENTANA M1 clone-specific MLH1 aberrant stainin...

B. G. Betini, W. D. Martins · 0 citations
Open access Oct 2026

Lynch syndrome associated with the pathogenic MSH2 p.A230Lfs*16 variant presenting with sequential colorectal, endometrial, and ampullary cancers: a case report

A rare Lynch syndrome patient carrying a known pathogenic germline variant complicated with sequential colorectal, endometrial and ampullary carcinoma is reported, emphasizing the importance of early LS screening and lifelong surveillance for individuals with multiple primary malignancies.

Yu Hei, Zhao-Shuai Ji, Li-Jun Jiao et al. · 0 citations
Case report Open access Oct 2026

Case Report: Metachronous multiple primary neoplasms in a carrier of germline MSH2 c.958dupA Lynch syndrome

Introduction Lynch syndrome is an autosomal dominant hereditary cancer syndrome caused by germline mutations in DNA mismatch repair (MMR) genes, conferring elevated risks of colorectal, endometrial, gastric, ovarian and other malignancies. We report a 38-year-old woman with a germline MSH2 c.958dupA (p.Thr320Asnfs*13)...

Li-Qiong Wang, Ping Li, Duan-Lin Hu et al. · 0 citations
Open access Sep 2026

Lynch Syndrome in a Young Male Patient: A Rare Case Report with Diagnostic Considerations

Introduction: Lynch syndrome, (LS), or hereditary nonpolyposis colorectal cancer (HNPCC), is an autosomal dominant inherited cancer syndrome primarily caused by germline mutations in DNA mismatch repair (MMR) genes, particularly MLH1 and MSH2. These mutations cause microsatellite instability (MSI), a hallmark of LS-ass...

A. D. Farista, Vidi Orba Busro, Suyata Suyata et al. · 0 citations
Open access Nov 2026

110 ALK-Rearranged Renal Cell Carcinoma Mimicking Metanephric Adenoma in a Young Woman

ALK-rearranged renal cell carcinoma (ALK-RCC) is a rare malignancy that can diagnostically overlap with benign metanephric adenoma (MA). Distinguishing them is critical; ALK-RCC is a malignant tumor potentially responsive to targeted therapies, whereas MA is a benign lesion. In this case, a 32-year-old fem...

Haadiyah Rabbani, Ping Zhang · 0 citations
Open access Oct 2026

Extrarenal TFE3-Rearranged Renal Cell Carcinoma: Diagnostic Challenges in an Uncommon Scalp Localization.

OBJECTIVE TFE3-rearranged renal cell carcinoma (RCC) is a rare subtype of MiT family translocation-associated tumors, usually arising in the kidney of young patients. Extrarenal presentations are exceptionally uncommon and represent a major diagnostic challenge. To our knowledge, only two cases of extrarenal TFE3-rearr...

Imane Tazi, M. Allaoui, M. R. El Ochi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.